PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q4 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Symbol: PLSE on Nasdaq
Shares outstanding: 69,110,956
Price per share: $13.73
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 5,847,549
Total reported value: $103,501,776
% of total 13F portfolios: 0%
Share change: -138,648
Value change: -$2,129,460
Number of holders: 82
Price from insider filings: $13.73

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
DUGGAN ROBERT W	71%		$782,629,053		48,792,335		Robert W. Duggan	18 Dec 2024

As of 30 Sep 2025, 82 institutional investors reported holding 5,847,549 shares of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE). This represents 8.5% of the company’s total 69,110,956 outstanding shares.

Institutional Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	16,070	$220,641	+$214,968			$13.73	4
2025 Q3	5,847,549	$103,501,776	-$2,129,460	$424,800	$520,380	$17.70	82
2025 Q2	5,984,466	$90,308,611	+$4,349,324	$507,024	$565,875	$15.09	85
2025 Q1	5,678,459	$91,368,048	-$5,798,192	$978,272	$1,224,449	$16.09	82
2024 Q4	5,966,828	$103,883,495	+$5,152,803	$905,320	$1,652,209	$17.41	71
2024 Q3	5,612,248	$98,415,317	+$11,001,271	$1,476,868	$2,429,290	$17.54	71
2024 Q2	4,831,221	$54,059,716	+$1,064,725	$1,076,478	$1,547,577	$11.19	58
2024 Q1	4,757,094	$41,427,610	+$3,127,410	$820,482	$2,079,077	$8.71	60
2023 Q4	4,336,775	$53,078,732	+$7,721,844	$629,136	$3,088,152	$12.24	49
2023 Q3	3,863,247	$15,567,183	+$685,567	$4,836	$756,834	$4.03	43
2023 Q2	3,635,816	$26,140,973	+$8,715,726	$0	$146,676	$7.19	45
2023 Q1	2,354,177	$7,909,339	-$336,779	$31,920	$774,144	$3.36	23
2022 Q4	2,458,733	$6,808,837	+$269,593	$364,809	$934,044	$2.77	26
2022 Q3	2,441,628	$5,607,741	-$1,248,742		$1,036,000	$2.30	26
2022 Q2	2,518,560	$3,852,369	-$2,216,619		$145,000	$1.53	32
2022 Q1	2,294,012	$11,156,031	-$5,142,939	$0	$0	$4.86	48
2021 Q4	4,070,521	$60,342,400	-$1,060,646	$536,000	$184,000	$14.81	47
2021 Q3	4,104,928	$88,740,150	+$4,809,728	$1,002,000	$2,091,000	$21.60	53
2021 Q2	3,149,110	$51,649,286	-$3,615,742	$0	$371,000	$16.40	53
2021 Q1	3,218,774	$76,217,396	+$4,377,745	$358,000	$590,000	$23.68	56
2020 Q4	2,409,307	$57,493,825	+$3,560,898	$291,000	$604,000	$23.86	52
2020 Q3	2,250,048	$26,525,968	-$333,700		$0	$11.79	42
2020 Q2	2,286,531	$23,915,075	+$5,956,207		$386,000	$10.46	46
2020 Q1	2,204,926	$15,783,060	-$293,278		$220,000	$7.16	41
2019 Q4	2,180,512	$29,237,376	+$1,113,742		$268,000	$13.41	42
2019 Q3	2,088,552	$32,245,638	+$1,164,345		$317,000	$15.44	40
2019 Q2	2,010,708	$26,537,447	+$2,483,150		$1,362,000	$13.20	36
2019 Q1	1,866,784	$32,835,736	+$2,391,811		$1,631,000	$17.59	40
2018 Q4	1,779,297	$20,387,240	+$69,354			$11.46	40
2018 Q3	1,754,783	$24,857,704	+$1,367,657	$0	$0	$14.19	44
2018 Q2	1,669,627	$25,260,353	+$2,516,067	$183,000	$502,000	$15.13	42
2018 Q1	1,511,798	$20,460,782	-$5,048,940	$267,000	$537,000	$13.53	43
2017 Q4	1,828,201	$43,140,696	+$7,733,870	$2,638,000	$637,000	$23.60	47
2017 Q3	1,520,354	$28,292,323	+$1,697,420	$2,805,000	$1,117,000	$18.61	43
2017 Q2	1,361,677	$47,014,976	+$32,263,197			$34.53	46
2017 Q1	435,988	$8,893,000	+$5,089,665			$20.39	29
2016 Q4	213,382	$1,373,000	-$169,374			$6.50	10
2016 Q3	241,681	$1,522,000	+$613,375			$6.31	12
2016 Q2	163,513	$734,000	+$733,998			$4.49	7